Poor in vitro activity of ceftazidime/avibactam, ceftolozane/tazobactam, and meropenem/vaborbactam against carbapenem-resistant Pseudomonas aeruginosa in India: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2018-2021

被引：3
|
作者：
Lee, Yu-Lin [1 ,2 ,3 ]
Hsueh, Po-Ren [4 ,5 ,6 ,7 ,8 ,9 ]
机构：
[1] Chung Shan Med Univ Hosp, Dept Internal Med, Taichung, Taiwan
[2] Chung Shan Med Univ, Sch Med, Taichung, Taiwan
[3] Natl Chung Hsing Univ, Inst Genom & Bioinformat, PhD Program Med Biotechnol, Taichung, Taiwan
[4] China Med Univ, China Med Univ Hosp, Sch Med, Dept Lab Med, Taichung, Taiwan
[5] China Med Univ, China Med Univ Hosp, Sch Med, Dept Internal Med, Taichung, Taiwan
[6] Natl Taiwan Univ, Dept Lab Med, Natl Taiwan Univ Hosp, Coll Med, Taipei, Taiwan
[7] Natl Taiwan Univ, Natl Taiwan Univ Hosp, Dept Internal Med, Coll Med, Taipei, Taiwan
[8] China Med Univ, Dept Lab Med, Taichung, Taiwan
[9] China Med Univ, Dept Internal Med, Taichung, Taiwan
来源：
JOURNAL OF INFECTION | 2023年 / 87卷 / 01期
关键词：
TRENDS;
D O I：
10.1016/j.jinf.2023.04.013
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：E1 / E4
页数：4
相关论文
共 50 条
  • [1] Poor in vitro activity of ceftazidime/avibactam against carbapenem-resistant Escherichia coli and Klebsiella pneumoniae in India: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2018-2021
    Hsueh, Chun-Chung
    Lai, Chih-Cheng
    Tsai, Ya-Wen
    Ko, Wen-Chien
    Wang, Jiun-Ling
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2024, 63 (03)
  • [2] The ERACE-PA Global Surveillance Program: Ceftolozane/tazobactam and Ceftazidime/avibactam in vitro Activity against a Global Collection of Carbapenem-resistant Pseudomonas aeruginosa
    Christian M. Gill
    Elif Aktaþ
    Wadha Alfouzan
    Lori Bourassa
    Adrian Brink
    Carey-Ann D. Burnham
    Rafael Canton
    Yehuda Carmeli
    Marco Falcone
    Carlos Kiffer
    Anna Marchese
    Octavio Martinez
    Spyros Pournaras
    Michael Satlin
    Harald Seifert
    Abrar K. Thabit
    Kenneth S. Thomson
    Maria Virginia Villegas
    David P. Nicolau
    [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2021, 40 : 2533 - 2541
  • [3] The ERACE-PA Global Surveillance Program: Ceftolozane/tazobactam and Ceftazidime/avibactam in vitro Activity against a Global Collection of Carbapenem-resistant Pseudomonas aeruginosa
    Gill, Christian M.
    Aktap, Elif
    Alfouzan, Wadha
    Bourassa, Lori
    Brink, Adrian
    Burnham, Carey-Ann D.
    Canton, Rafael
    Carmeli, Yehuda
    Falcone, Marco
    Kiffer, Carlos
    Marchese, Anna
    Martinez, Octavio
    Pournaras, Spyros
    Satlin, Michael
    Seifert, Harald
    Thabit, Abrar K.
    Thomson, Kenneth S.
    Villegas, Maria Virginia
    Nicolau, David P.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2021, 40 (12) : 2533 - 2541
  • [4] Geographic patterns of global isolates of carbapenem-resistant Klebsiella pneumoniae and the activity of ceftazidime/avibactam, meropenem/vaborbactam, and comparators against these isolates: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2020
    Lee, Yu-Lin
    Ko, Wen-Chien
    Hsueh, Po-Ren
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2022, 60 (5-6)
  • [5] In vitro activities of ceftazidime-avibactam, ceftolozane-tazobactam, meropenem-vaborbactam and other comparators against Pseudomonas aeruginosa isolates with discrepant resistance to carbapenems: Data from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2012-2021
    Lee, Yu-Lin
    Ko, Wen-Chien
    Hsueh, Po-Ren
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2023, 62 (02)
  • [6] Verification of Ceftazidime-Avibactam and Ceftolozane-Tazobactam Susceptibility Testing Methods against Carbapenem-Resistant Enterobacteriaceae and Pseudomonas aeruginosa
    Shields, Ryan K.
    Clancy, Cornelius J.
    Pasculle, A. William
    Press, Ellen G.
    Haidar, Ghady
    Hao, Binghua
    Chen, Liang
    Kreiswirth, Barry N.
    Nguyen, M. Hong
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2018, 56 (02)
  • [7] Antimicrobial susceptibility profile of ceftolozane/tazobactam, ceftazidime/avibactam and cefiderocol against carbapenem-resistant Pseudomonas aeruginosa clinical isolates from Türkiye
    Buyukyanbolu, Ecem
    Genc, Leyla
    Cyr, Elizabeth A.
    Karakus, Mehmet
    Comert, Fusun
    Otlu, Baris
    Aktas, Elif
    Nicolau, David P.
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2024, 43 (09) : 1787 - 1794
  • [8] Evaluation of the In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Meropenem-Resistant Pseudomonas aeruginosa Isolates
    Buehrle, Deanna J.
    Shields, Ryan K.
    Chen, Liang
    Hao, Binghua
    Press, Ellen G.
    Alkrouk, Ammar
    Potoski, Brian A.
    Kreiswirth, Barry N.
    Clancy, Cornelius J.
    Nguyen, M. Hong
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (05) : 3227 - 3231
  • [9] Evaluation of In Vitro Activity of Ceftolozane/Tazobactam and Ceftazidime/Avibactam Against Carbapenem-Resistant Pseudomonas aeruginosa Strains and Mechanisms of Carbapenem Resistance: Data from Tertiary Care Hospital
    Hazirolan, Gulsen
    Ozkul, Ceren
    [J]. JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2023, 16 (03)
  • [10] Antimicrobial activities of ceftazidime/avibactam, ceftolozane/tazobactam, imipenem/relebactam, meropenem/vaborbactam, and comparators against Pseudomonas aeruginosa from patients with skin and soft tissue infections
    Sader, Helio S.
    Castanheira, Mariana
    Duncan, Leonard R.
    Mendes, Rodrigo E.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 113 : 279 - 281
12345